Target (TGT) is set to report fourth-quarter earnings on Tuesday morning, with analysts seeing substantial upside for the retailer's stock.

Analysts' ratings are split, with five "buy" and seven "hold" ratings among the brokers who currently follow Target and are tracked by Visible Alpha. ♊Their average price target of just under $144 suggests about 15% upside to Monday's intraday price.

The retailer is expected to report revenue of $30.77 billion for the quarter and adjusted earnings per share of $2.26, down 3.6% and 24%, respectively, from the same time a year ago. At the same time, analysts expect 澳洲幸运5官方开奖结果体彩网:comparable store sales to rise 1.39% year-over-year, a consensus figure that Morgan Stanley analysts noted this week has risen since Target 澳洲幸运5官方开奖结果体彩网:lifted its comparaꦛble sales projection in January.

Analysts Expect Conservative 2025 Outlook𓂃, Q🅘uestion CEO Succession

Analysts from JPMorgan, Oppenheimer, and Morgan Stanley all said in recent notes that they expect Target will likely follow some of its retail rivals 澳洲幸运5官方开奖结果体彩网:like Walmart (WMT) and 澳洲幸运5官方开奖结果体彩网:Home Depot (HD) and remain conservative in their first-quarter and 2025 projections.

Despite a potential conservative 2025 forecast—and concerns over the impact of tariffs and inflation on 澳洲幸运5官方开奖结果体彩网:discretionary spending—Oppenheimer analysts said they "continue to believe shares have bottomed" and said they would "take advantage of any volatility" after the report. They noted that Target shares have fallen after two of the past four earnings reports, with double-digit swings after 💃four of the last five.

JPMorgan and Morgan Stanley analysts also raised the question of 澳洲幸运5官方开奖结果体彩网:succession planning entering 2025, as CEO Brian Cornell recently passed 10 years in the top job. JPMorgan analysts said Cornell planned to stay for three more years as of September 2022, and said they believe an inte✱rnal candidate to rep🌱lace him is "most likely."

Target shares have lost close to 18% of their value over🙈 the last 12 months, at $124.24 in intraday trading Monday.

UPDATE—March 3, 2025: This article has been updated since it was first published to reflect more recent analyst estimates and share price values.